First Command Advisory Services’s Alnylam Pharmaceuticals ALNY Stock Holding History

First Command Advisory Services's ALNY Position: Q2 2026 in Review

First Command Advisory Services increased its Alnylam Pharmaceuticals (ALNY) stake by 1,208% in Q2 2026, buying an estimated $43.7K and bringing the position to 157 shares worth $47.3K. The position accounts for ﹤0.01% of the portfolio, ranked #455.

First Command Advisory Services first reported a position in ALNY in Q4 2025 and has held it in 3 quarters since. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

• First Command Advisory Services held 157 shares of Alnylam Pharmaceuticals worth $47.3K as of Q2 2026.
• First Command Advisory Services bought 145 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $43.7K.
• Alnylam Pharmaceuticals made up ﹤0.01% of First Command Advisory Services's portfolio in Q2 2026, its #455 holding.
• First Command Advisory Services first reported a position in Alnylam Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
• 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on First Command Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.